1
|
Muralidar S, Ambi SV, Sekaran S and
Krishnan UM: The emergence of COVID-19 as a global pandemic:
Understanding the epidemiology, immune response and potential
therapeutic targets of SARS-CoV-2. Biochimie. 179:85–100.
2020.PubMed/NCBI View Article : Google Scholar
|
2
|
World Health Organization (WHO):
Coronavirus disease (COVID-19). WHO, Geneva, 2023. https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
|
3
|
Zhang B, Wu Q, Yin L, Zhang J, Gao W, Chen
H and Ni H: Current diagnostic and therapeutic approaches for
severe acute respiratory syndrome coronavirus-2 (SARS-COV-2) and
the role of nanomaterial-based theragnosis in combating the
pandemic. Nanotechnol Rev. 12(20230155)2023.
|
4
|
Rastogi M, Pandey N, Shukla A and Singh
SK: SARS coronavirus 2: From genome to infectome. Respir Res.
21(318)2020.PubMed/NCBI View Article : Google Scholar
|
5
|
Dhama K, Khan S, Tiwari R, Sircar S, Bhat
S, Malik YS, Singh KP, Chaicumpa W, Bonilla-Aldana DK and
Rodriguez-Morales AJ: Coronavirus disease 2019-COVID-19. Clin
Microbiol Rev. 33:e00028–20. 2020.PubMed/NCBI View Article : Google Scholar
|
6
|
Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y,
Hou C, Wang H, Liu J, Yang D, et al: Role of angiotensin-converting
enzyme 2 (ACE2) in COVID-19. Crit Care. 24(422)2020.PubMed/NCBI View Article : Google Scholar
|
7
|
Zhang H, Penninger JM, Li Y, Zhong N and
Slutsky AS: Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2
receptor: Molecular mechanisms and potential therapeutic target.
Intensive Care Med. 46:586–590. 2020.PubMed/NCBI View Article : Google Scholar
|
8
|
El Hassan M, Assoum H, Bukharin N, Al
Otaibi H, Mofijur M and Sakout A: A review on the transmission of
COVID-19 based on cough/sneeze/breath flows. Eur Phys J Plus.
137(1)2022.PubMed/NCBI View Article : Google Scholar
|
9
|
Vuille-Dit-Bille RN, Liechty KW, Verrey F
and Guglielmetti LC: SARS-CoV-2 receptor ACE2 gene expression in
small intestine correlates with age. Amino Acids. 52:1063–1065.
2020.PubMed/NCBI View Article : Google Scholar
|
10
|
Reich P and Elward A: Infection prevention
during the coronavirus disease 2019 pandemic. Infect Dis Clin North
Am. 36:15–37. 2022.PubMed/NCBI View Article : Google Scholar
|
11
|
Popa MF, Deacu S, Neculai-Cândea L, Radu
S, Pricop Ș, Mocanu L, Gheju A and Tăbîrcă DD: Virus-associated
hemophagocytic lymphohistiocystosis-the severe course expression in
SARS-COV-2 infection? Rom J Leg Med. 28:1–7. 2020.
|
12
|
Centers for Disease Control and Prevention
(CDC): Symptoms of COVID-19. CDC, Atlanta, GA, 2020. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.
|
13
|
Nicolae M, Mihai CM, Chisnoiu T, Balasa
AL, Frecus CE, Mihai L, Lupu VV, Ion I, Pantazi AC, Nelson Twakor
A, et al: Immunomodulatory effects of vitamin D in respiratory
tract infections and COVID-19 in children. Nutrients.
15(3430)2023.PubMed/NCBI View Article : Google Scholar
|
14
|
Mocanu A, Lazureanu VE, Marinescu AR, Cut
TG, Laza R, Rusu LC, Marza AM, Nelson-Twakor A, Negrean RA, Popescu
IM and Mederle AO: A retrospective assessment of laboratory
findings and cytokine markers in severe SARS-CoV-2 infection among
patients of roma population. J Clin Med. 11(6777)2022.PubMed/NCBI View Article : Google Scholar
|
15
|
Lin W, Gao F, Wang X, Qin N, Chen X, Tam
KY, Zhang C, Zhang M and Sha O: The oral manifestations and related
mechanisms of COVID-19 caused by SARS-CoV-2 infection. Front Cell
Neurosci. 16(1006977)2023.PubMed/NCBI View Article : Google Scholar
|
16
|
Xu M, Fralick D, Zheng JZ, Wang B, Tu XM
and Feng C: The differences and similarities between two-sample
T-test and paired T-test. Shanghai Arch Psychiatry. 29:184–188.
2017.PubMed/NCBI View Article : Google Scholar
|
17
|
Dahiru T: P-value, a true test of
statistical significance? A cautionary note. Ann Ib Postgrad Med.
6:21–26. 2008.PubMed/NCBI View Article : Google Scholar
|
18
|
Tanha K, Mohammadi N and Janani L:
P-value: What is and what is not. Med J Islam Repub Iran.
31(65)2017.PubMed/NCBI View Article : Google Scholar
|
19
|
Bonovas S and Piovani D: On P-values and
statistical significance. J Clin Med. 12(900)2023.PubMed/NCBI View Article : Google Scholar
|
20
|
Einav S and O'Connor M: P-values and
significance: The null hypothesis that they are not related is
correct. J Crit Care. 54:159–162. 2019.PubMed/NCBI View Article : Google Scholar
|
21
|
Dettori JR, Norvell DC and Chapman JR:
Seeing the forest by looking at the trees: How to interpret a
meta-analysis forest plot. Global Spine J. 11:614–616.
2021.PubMed/NCBI View Article : Google Scholar
|
22
|
Verhagen AP and Ferreira ML: Forest plots.
J Physiother. 60:170–173. 2014.PubMed/NCBI View Article : Google Scholar
|
23
|
Meena S: Difference between Z-test and
T-test. Analytics Vidhya, 2024. https://www.analyticsvidhya.com/blog/2020/06/statistics-analytics-hypothesis-testing-z-test-t-test/.
|
24
|
El-Saber Batiha G, Al-Gareeb AI, Saad HM
and Al-Kuraishy HM: COVID-19 and corticosteroids: A narrative
review. Inflammopharmacology. 30:1189–1205. 2022.PubMed/NCBI View Article : Google Scholar
|
25
|
Shamsundara M and Jayalakshmi L:
Anosmia-an effect of COVID-19 infection-review. Indian J
Otolaryngol Head Neck Surg. 75 (Suppl 1):S815–S821. 2023.PubMed/NCBI View Article : Google Scholar
|
26
|
Rashid RA, Zgair A and Al-Ani RM: Effect
of nasal corticosteroid in the treatment of anosmia due to
COVID-19: A randomised double-blind placebo-controlled study. Am J
Otolaryngol. 42(103033)2021.PubMed/NCBI View Article : Google Scholar
|
27
|
Richman DD and Nathanson N: Antiviral
therapy. Viral Pathogenesis. 271–87. 2016.
|
28
|
Hornuss D, Lange B, Schröter N, Rieg S,
Kern WV and Wagner D: Anosmia in COVID-19 patients. Clin Microbiol
Infect. 26:1426–1427. 2020.PubMed/NCBI View Article : Google Scholar
|
29
|
Deacu M, Enciu M, Nicolau AA, Bălţătescu
GI, Neculai-Cândea LS, Deacu S and Popa MF: Morphopathological
features induced by SARS-CoV-2 infection-a series of 57 autopsies.
Histol Histopathol. 38:513–524. 2023.PubMed/NCBI View Article : Google Scholar
|
30
|
Yale Medicine: Loss of Smell (Anosmia).
Yale University, 2022. https://www.yalemedicine.org/conditions/smell-and-taste-disorders#:~:text=What%20is%20anosmia%3F,a%20sinus%20infection%2C%20for%20example.
|
31
|
Rahmah L, Abarikwu SO, Arero AG, Essouma
M, Jibril AT, Fal A, Flisiak R, Makuku R, Marquez L, Mohamed K, et
al: Oral antiviral treatments for COVID-19: Opportunities and
challenges. Pharmacol Rep. 74:1255–1278. 2022.PubMed/NCBI View Article : Google Scholar
|
32
|
Ghanbari R, Teimoori A, Sadeghi A,
Mohamadkhani A, Rezasoltani S, Asadi E, Jouyban A and Sumner SC:
Existing antiviral options against SARS-CoV-2 replication in
COVID-19 patients. Future Microbiol. 15:1747–1758. 2020.PubMed/NCBI View Article : Google Scholar
|
33
|
Mocanu A, Noja GG, Istodor AV, Moise G,
Leretter M, Rusu LC, Marza AM and Mederle AO: Individual
characteristics as prognostic factors of the evolution of
hospitalized COVID-19 romanian patients: A comparative
observational study between the first and second waves based on
gaussian graphical models and structural equation modeling. J Clin
Med. 10(1958)2021.PubMed/NCBI View Article : Google Scholar
|
34
|
Termansen MB and Frische S: Fecal-oral
transmission of SARS-CoV-2: A systematic review of evidence from
epidemiological and experimental studies. Am J Infect Control.
51:1430–1437. 2023.PubMed/NCBI View Article : Google Scholar
|
35
|
Mocanu A, Lazureanu V, Cut T, Laza R,
Musta V, Nicolescu N, Marinescu A, Nelson-Twakor A, Dumache R and
Mederle O: Angiocatheter decompression on a Covid-19 patient with
severe pneumonia, pneumothorax, and subcutaneous emphysema. Clin
Lab. 68:2022.PubMed/NCBI View Article : Google Scholar
|
36
|
Carotti M, Salaffi F, Sarzi-Puttini P,
Agostini A, Borgheresi A, Minorati D, Galli M, Marotto D and
Giovagnoni A: Chest CT features of coronavirus disease 2019
(COVID-19) pneumonia: Key points for radiologists. Radiol Med.
125:636–646. 2020.PubMed/NCBI View Article : Google Scholar
|
37
|
Gori A, Leone F, Loffredo L, Cinicola BL,
Brindisi G, De Castro G, Spalice A, Duse M and Zicari AM:
COVID-19-related anosmia: The olfactory pathway hypothesis and
early intervention. Front Neurol. 11(956)2020.PubMed/NCBI View Article : Google Scholar
|
38
|
Cattaneo C, Pagliarini E, Mambrini SP,
Tortorici E, Mené R, Torlasco C, Perger E, Parati G and Bertoli S:
Changes in smell and taste perception related to COVID-19
infection: A case-control study. Sci Rep. 12(8192)2022.PubMed/NCBI View Article : Google Scholar
|
39
|
Chen L, Zhao J, Peng J, Li X, Deng X, Geng
Z, Shen Z, Guo F, Zhang Q, Jin Y, et al: Detection of SARS-CoV-2 in
saliva and characterization of oral symptoms in COVID-19 patients.
Cell Prolif. 53(e12923)2020.PubMed/NCBI View Article : Google Scholar
|
40
|
Ziuzia-Januszewska L and Januszewski M:
Pathogenesis of olfactory disorders in COVID-19. Brain Sci.
12(449)2022.PubMed/NCBI View Article : Google Scholar
|
41
|
Mulabbi EN, Tweyongyere R and Byarugaba
DK: The history of the emergence and transmission of human
coronaviruses. Onderstepoort J Vet Res. 88:e1–e8. 2021.PubMed/NCBI View Article : Google Scholar
|
42
|
de Oliveira WQ, De Sousa PHM and Pastore
GM: Olfactory and gustatory disorders caused by COVID-19: How to
regain the pleasure of eating? Trends Food Sci Technol.
122:104–109. 2022.PubMed/NCBI View Article : Google Scholar
|
43
|
Fisher J, Monette DL, Patel KR, Kelley BP
and Kennedy M: COVID-19 associated parotitis. Am J Emerg Med.
39:254.e1–254.e3. 2021.PubMed/NCBI View Article : Google Scholar
|
44
|
Lechien JR, Chetrit A, Chekkoury-Idrissi
Y, Distinguin L, Circiu M, Saussez S, Berradja N, Edjlali M, Hans S
and Carlier R: Parotitis-like symptoms associated with COVID-19,
France, March-April 2020. Emerg Infect Dis. 26:2270–2271.
2020.PubMed/NCBI View Article : Google Scholar
|
45
|
Templer JW: Parotitis: Practice
Essentials, Background, Pathophysiology. Medscape, 2022. https://emedicine.medscape.com/article/882461-overview?form=fpf.
Accessed April 11, 2022.
|
46
|
Gebretsadik HG: An update on oral clinical
courses among patients with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection: A clinical follow-up (a
prospective prevalent cohort) study. PLoS One.
17(e0275817)2022.PubMed/NCBI View Article : Google Scholar
|
47
|
Wilson M and Pandey S: Parotitis. (Updated
2023 Jun 25). In: StatPearls (Internet). StatPearls Publishing,
Treasure Island, FL, 2024.
|
48
|
Friedrich RE, Droste TL, Angerer F, Popa
B, Koehnke R, Gosau M and Knipfer C: COVID-19-associated parotid
gland abscess. In Vivo. 36:1349–1353. 2022.PubMed/NCBI View Article : Google Scholar
|
49
|
V'kovski P, Kratzel A, Steiner S, Stalder
H and Thiel V: Coronavirus biology and replication: Implications
for SARS-CoV-2. Nat Rev Microbiol. 19:155–170. 2021.PubMed/NCBI View Article : Google Scholar
|
50
|
Nuno-Gonzalez A, Martin-Carrillo P,
Magaletsky K, Martin Rios MD, Herranz Mañas C, Artigas Almazan J,
García Casasola G, Perez Castro E, Gallego Arenas A, Mayor
Ibarguren A, et al: Prevalence of mucocutaneous manifestations in
666 patients with COVID-19 in a field hospital in Spain: oral and
palmoplantar findings. Br J Dermatol. 184:184–185. 2021.PubMed/NCBI View Article : Google Scholar
|
51
|
Chern A, Famuyide AO, Moonis G and Lalwani
AK: Sialadenitis: A possible early manifestation of COVID-19.
Laryngoscope. 130:2595–2597. 2020.PubMed/NCBI View Article : Google Scholar
|
52
|
Mocanu A, Lazureanu VE, Laza R, Marinescu
AR, Cut TG, Sincaru SV, Marza AM, Popescu IM, Herlo LF,
Nelson-Twakor A, et al: Laboratory findings and clinical outcomes
of ICU-admitted COVID-19 patients: A retrospective assessment of
particularities identified among Romanian minorities. J Pers Med.
13(195)2023.PubMed/NCBI View Article : Google Scholar
|
53
|
Tong JY, Wong A, Zhu D, Fastenberg JH and
Tham T: The prevalence of olfactory and gustatory dysfunction in
COVID-19 patients: A systematic review and meta-analysis.
Otolaryngol Head Neck Surg. 163:3–11. 2020.PubMed/NCBI View Article : Google Scholar
|
54
|
Amorim Dos Santos J, Normando AGC,
Carvalho da Silva RL, Acevedo AC, De Luca Canto G, Sugaya N,
Santos-Silva AR and Guerra ENS: Oral manifestations in patients
with COVID-19: A living systematic review. J Dent Res. 100:141–154.
2021.PubMed/NCBI View Article : Google Scholar
|
55
|
Iranmanesh B, Khalili M, Amiri R, Zartab H
and Aflatoonian M: Oral manifestations of COVID-19 disease: A
review article. Dermatol Ther. 34(e14578)2021.PubMed/NCBI View Article : Google Scholar
|
56
|
Orilisi G, Mascitti M, Togni L,
Monterubbianesi R, Tosco V, Vitiello F, Santarelli A, Putignano A
and Orsini G: Oral manifestations of COVID-19 in hospitalized
patients: A systematic review. Int J Environ Res Public Health.
18(12511)2021.PubMed/NCBI View Article : Google Scholar
|
57
|
Drozdzik A and Drozdzik M: Oral pathology
in COVID-19 and SARS-CoV-2 infection-molecular aspects. Int J Mol
Sci. 23(1431)2022.PubMed/NCBI View Article : Google Scholar
|
58
|
Jacobs M and Ellis C: Social connectivity
during the COVID-19 pandemic: Disparities among medicare
beneficiaries. J Prim Care Community Health.
12(21501327211030135)2021.PubMed/NCBI View Article : Google Scholar
|
59
|
Tahmasebi E, Keshvad A, Alam M, Abbasi K,
Rahimi S, Nouri F, Yazdanian M, Tebyaniyan H, Heboyan A and
Fernandes GVO: Current infections of the orofacial region:
Treatment, diagnosis, and epidemiology. Life (Basel).
13(269)2023.PubMed/NCBI View Article : Google Scholar
|
60
|
Faculty of Public Health: Biases and
Confounding. Health Knowledge. Faculty of Public Health, London,
2018. https://www.healthknowledge.org.uk/public-health-textbook/research-methods/1a-epidemiology/biases.
|
61
|
Althubaiti A: Information bias in health
research: Definition, pitfalls, and adjustment methods. J
Multidiscip Healthc. 9:211–217. 2016.PubMed/NCBI View Article : Google Scholar
|
62
|
Muthyam AK, Reddy MP, Kulkarni S, Srilatha
A, Sahithi K and Satyanarayana D: Oral manifestations in COVID-19
patients: An observational study. J Family Med Prim Care.
11:1000–1005. 2022.PubMed/NCBI View Article : Google Scholar
|
63
|
Pérez-Jardón A, Pérez-Sayáns M,
Peñamaría-Mallón M, Otero-Rey E, Velasco-Ortega E, López-López J,
Martínez-González JM and Blanco-Carrión A: Xerostomia, the
perception of general and oral health and health risk behaviours in
people over 65 years of age. BMC Geriatr. 22(982)2022.PubMed/NCBI View Article : Google Scholar
|